Illumina, Inc. (ILMN)
NasdaqGS: ILMN
· 即時價格 · USD
218.22
-3.44 (-1.55%)
收盤價: Sep 04, 2026, 3:59 PM
220.01
+0.82%
盤後: 7:59 PM
股價、關鍵數字和最新消息,都在這一頁。
Illumina, Inc.(ILMN)股價、分析與資料
-1.55% (1D)
| 買價 | 204.25 |
| 市值 | 33B |
| 營收 (ttm) | 4.49B |
| 淨利(ttm) | 824M |
| 1.47 | |
| 5.36 | |
| 40.71 | |
| 35.78 | |
| P/B (ttm) | 11.61 |
| P/S (ttm) | 7.33 |
| 財報日期 | Oct 29, 2026 |
| 賣價 | 226.9 |
| 成交量 | 1,682,969 |
| 20 日平均成交量 | 1,928,801 |
| 開盤價 | 216.74 |
| 前收盤價 | 221.66 |
| 當日區間 | 213.95 - 219.57 |
| 52 週範圍 | 88.00 - 231.81 |
| 分析師 | 購買 |
| 目標價 | 211 (-3.31%) |
| 股利 | n/a |
| 除息日 | n/a |
關於 ILMN
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which s...
完整的公司簡介財報驚奇
Illumina 已於 Jul 30, 2026 公布季度財報:
- 營收為 n/a 低於預期 $0, 年增 -100.00% 下滑.
- 每股盈餘為 1.31 超出預期 0.08, 年增 10.08% 成長.


